Disseminated intravascular coagulation (Q67594376)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1452511%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

review article

1 reference

title

Disseminated intravascular coagulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1452511%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

author name string

Bick RL

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1452511%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

publication date

1 December 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1452511%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

15 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1452511%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1452511%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1452511%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

1259-1285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1452511%20AND%20SRC:MED&resulttype=core&format=json

The behavior of alpha2-plasmin inhibitor in fibrinolytic states

15 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Clinical aspects of disseminated intravascular coagulation: a clinician's point of view

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

An objective study of alternative methods of heparin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Disseminated intravascular coagulation and related syndromes: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Hereditary hemorrhagic telangiectasia and disseminated intravascular coagulation: a new clinical syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

The clinical significance of fibrinogen degradation products

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Clinical hemostasis practice: the major impact of laboratory automation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Antithrombin III(AT-III) as a diagnostic aid in disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Clinical relevance of antithrombin III.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Diagnostic efficacy of the D-Dimer assay in disseminated intravascular coagulation (DIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Disseminated intravascular coagulation: a clinical/laboratory study of 48 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Clinical implications of molecular markers in hemostasis and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Disseminated intravascular coagulation and blood component therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Disseminated fibrin thromboembolism among neonates dying within 48 hours of birth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Ethanol Gelation: A Rapid Screening Test for Intravascular Coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Increased fibrinolysin with malignant disease. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Microangiopathic haemolytic anaemia: mechanisms of red-cell fragmentation: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Use of peptidyl-4-methoxy-2-naphthylamides to assay plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Mechanism of endotoxin interaction with human leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Identification and Some Properties of a New Fast-Reacting Plasmin Inhibitor in Human Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Hypercoagulability in patients with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Changes in the blood coagulation system associated with septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Heparin therapy in septicemia with disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Acquired hypofibrinogenaemia--'the defibrination syndrome.' A study of 7 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

The Role of Blood Platelets in the Precipitation of Soluble Fibrin by Endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Treatment of disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

A molecular model of plasmic degradation of crosslinked fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Studies on the generalized Shwartzman reaction. IV. Prevention of the local and generalized Shwartzman reactions with heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Bleeding and intravascular clotting in malignancy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Thrombosis with epsilon aminocaproic acid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Molecular aspects of defibrination in a reptilase-treated case of “Dead Fetus Syndrome”

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Severe acquired antithrombin III deficiency in relation to hepatic and renal insufficiency and intrauterine fetal death in late pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Chronic defibrination syndrome due to a giant hemangioma associated with microangiopathic hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

The premises involved in the clinical use of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

CAPILLARY HEMANGIOMA WITH EXTENSIVE PURPURA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

The Plasma Protamine Paracoagulation Test: Clinical and Laboratory Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

An evaluation of the euglobulin method for the determination of fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Characterization of Serum Fibrinogen and Fibrin Fragments Produced during Disseminated Intravascular Coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy (“Verbrauchskoagulopathie”)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

The defibrination syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Clinical Experience with Anticoagulant Therapy in the Management of Disseminated Intravascular Coagulation in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Development of hirudin as an antithrombotic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Therapeutic implications of disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Alterations in the blood coagulation system induced by bacterial endotoxin. I. In vivo (generalized Shwartzman reaction)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Pathogenesis and treatment of altered blood coagulability in patients with malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

HEMODYNAMIC ACTION OF VASOPRESSOR AND VASODEPRESSOR AGENTS IN ENDOTOXIN SHOCK

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Pathophysiologic and biochemical events in disseminated intravascular coagulation: dysregulation of procoagulant and anticoagulant pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

The “Hageman” connection: Interrelationships of blood coagulation, fibrino(geno)lysis, kinin generation, and complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Thrombolytic activity of defibrotide against old venous thrombi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Platelet Interaction with Polymerizing Fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

The incidence and significance of hemostatic abnormalities in patients with head injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Surface markers of fibrinogen and its physiologic derivatives revealed by antibody probes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Epsilon Aminocaproic Acid — A Dangerous Weapon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Hemorrhagic States during Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Hemorrhagic states during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Pathology of disseminated intravascular coagulation (DIC). Analysis of 26 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Intravascular coagulation in a case of Clostridium perfringens septicaemia: treatment by exchange transfusion and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

An immunoassay for human D dimer using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Chronic Intravascular Coagulation Syndrome Associated with Atherosclerotic Aortic Aneurysm

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Coagulation Profile and the Ethanol Gelation Test with Special Reference to Components Consumed during Coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Adult hyaline membrane disese: relationship to oxygen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Fibrin degradation products in thrombo-embolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Defibrinogenation after Intra-Amniotic Injection of Hypertonic Saline

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

MATERNAL PULMONARY EMBOLISM BY AMNIOTIC FLUID

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Relationship between abnormalities of coagulation and fibrinolysis and postoperative intracranial hemorrhage in head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Gabexate as a therapy for disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Role of high molecular weight kininogen in contact activation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

Determination of plasmin-α2-antiplasmin complex in plasma samples by means of a radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930274-0

7 January 2021

10.1016/S0889-8588(18)30274-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1452511%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference